(Q48336337)

10 February 2018

title

Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. (English)

1 reference

10 February 2018

0 references

8

Robert C Green

1 reference

10 February 2018

Susan LaRusse Eckert

1

1 reference

10 February 2018

Heather Katzen

2

1 reference

10 February 2018

J Scott Roberts

3

1 reference

10 February 2018

Melissa Barber

4

1 reference

10 February 2018

Lisa D Ravdin

5

1 reference

10 February 2018

Norman R Relkin

6

1 reference

10 February 2018

Peter J Whitehouse

7

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 December 2006

1 reference

10 February 2018

published in

Genetics in Medicine

1 reference

10 February 2018

volume

8

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

page(s)

746-751

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1097/01.gim.0000250197.44245.a3

exact match

0 references

cites work

Exploring the etiology of Alzheimer disease using molecular genetics

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Categorizing genetic tests to identify their ethical, legal, and social implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Predictive genetic testing for Alzheimer's disease: impact upon risk perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

The impact of genetic counselling on risk perception in women with a family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

The use of videotaped information in cancer genetic counselling: a randomized evaluation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Women's preferences and consultants' communication of risk in consultations about familial breast cancer: impact on patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Intended message versus message received in hypothetical physician risk communications: exploring the gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Effects of individualized breast cancer risk counseling: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Patients' resistance to risk information in genetic counseling for BRCA1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Determinants of priority for risk reduction: the role of worry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

General performance on a numeracy scale among highly educated samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

What do we mean by genetic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Fuzzy-trace theory and framing effects in choice: Gist extraction, truncation, and conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

Feeling at risk: How women interpret their familial breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000250197.44245.A3

10.1097/01.GIM.0000250197.44245.A3

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

Dimensions Publication ID

1032660069

0 references

Fatcat ID

release_vyak4iu7grdgxixuynyjr3hoai

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vyak4iu7grdgxixuynyjr3hoai

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

10 February 2018